EGDFF yields 20000000.00% · JNJ yields 2.13%● Live data
📍 EGDFF pulled ahead of the other in Year 1
Combined, EGDFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EGDFF + JNJ for your $10,000?
Energold Drilling Corp., together with its subsidiaries, provides drilling services to the mining and energy sectors primarily in North America, Mexico, the Caribbean, Central America, South America, Europe, and Africa. The company operates through three segments: Minerals, Energy, and Manufacturing. It offers mineral drilling services, including surface and underground drilling, and conventional drilling services; and oil sands coring, shot hole seismic, and geothermal and geotechnical drilling services, as well as water well drilling services, such as mine pit de-watering, mine water supply, mine hydrogeological characterization and well monitoring, and rural and urban water well drilling schemes, as well as offers horizontal directional drilling services. The company also designs and manufactures customized mineral exploration multipurpose rigs for reverse-air-blast drilling, wireline coring, conventional coring, and reverse-circulation drilling; geothermal, geotechnical, and water well rig applications; tools and consumables; borehole logging equipment; and mud conditioning equipment. It operates a fleet of 270 rigs. The company was incorporated in 1973 and is headquartered in Vancouver, Canada.
Full EGDFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.